help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikander, E.
Right arrow Articles by Tiitinen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikander, E.
Right arrow Articles by Tiitinen, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 3 1207-1212
Copyright © 2004 by The Endocrine Society

Effects of Phytoestrogens on Bone Turnover in Postmenopausal Women with a History of Breast Cancer

Eini Nikander, Merja Metsä-Heikkilä, Olavi Ylikorkala and Aila Tiitinen

Department of Obstetrics and Gynecology (E.N., M.M.-H., O.Y., A.T.), Helsinki University Central Hospital, FIN-00029 HUS, Helsinki, Finland; and Department of Obstetrics and Gynecology (E.N.), Jorvi Hospital, FIN-02740 Espoo, Finland

Address all correspondence and requests for reprints to: Dr. Eini Nikander, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, P.O. Box 140, FIN-00029 HUS, Helsinki, Finland. E-mail: eini.nikander{at}pp.fimnet.fi.

High phytoestrogen intake among Asian women has been thought to explain the low risk of bone fractures in these populations. In a randomized placebo-controlled trial we studied the effects of isoflavonoids on urinary output of the N-terminal cross-linked telopeptide of type I collagen, pyridinoline (Pyr), and deoxypyridinoline (Dpyr) (bone resorption markers) and serum levels of bone-specific alkaline phosphatase and N-terminal and C-terminal procollagen type I (bone formation markers). Fifty-five postmenopausal women with a history of breast cancer used phytoestrogens (114 mg of isoflavonoids) or placebo tablets daily for 3 months; the treatment regimens were then crossed over after a 2-month washout period. The markers were measured before and on the last day of each treatment period.

Bone resorption was reduced during phytoestrogen use, as reflected in falls in the urinary output of Pyr (9%; P = 0.001) and Dpyr (5%; P = 0.008). Compared with the placebo group, the fall in Dpyr was significant (P = 0.022) and the falls in Pyr (P = 0.084) and N-terminal cross-linked telopeptide of type I collagen (P = 0.082) showed a trend toward significance. Bone formation markers were not affected by this regimen.

Thus, isoflavonoid-induced inhibition of bone resorption may contribute to the low risk of osteoporosis in Asian women.

This work was supported by grants from research funds of Jorvi Hospital and Helsinki University Central Hospital and the Juho Vainio Foundation.

Abbreviations: BAP, Bone-specific alkaline phosphatase; BMD, bone mineral density; Dpyr, deoxypyridinoline; HRT, hormone replacement therapy; NTx, cross-linked N-terminal telopeptide of type I collagen; PICP, procollagen type I C-terminal propeptide; PINP, procollagen type I N-terminal propeptide; Pyr, pyridinoline.




This article has been cited by other articles:


Home page
J. Nutr.Home page
Y. Zhang, Q. Li, H.-Y. Wan, W. G. Helferich, and M.-S. Wong
Genistein and a Soy Extract Differentially Affect Three-Dimensional Bone Parameters and Bone-Specific Gene Expression in Ovariectomized Mice
J. Nutr., December 1, 2009; 139(12): 2230 - 2236.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Hooper, J.J. Ryder, M.S. Kurzer, J.W. Lampe, M.J. Messina, W.R. Phipps, and A. Cassidy
Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis
Hum. Reprod. Update, July 1, 2009; 15(4): 423 - 440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the American Heart Association Nutrition Commi
Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee
Circulation, February 21, 2006; 113(7): 1034 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
X. Zhang, X.-O. Shu, H. Li, G. Yang, Q. Li, Y.-T. Gao, and W. Zheng
Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women
Arch Intern Med, September 12, 2005; 165(16): 1890 - 1895.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Nikander, A. Tiitinen, K. Laitinen, M. Tikkanen, and O. Ylikorkala
Effects of Isolated Isoflavonoids on Lipids, Lipoproteins, Insulin Sensitivity, and Ghrelin in Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3567 - 3572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society